97613039 - CYCLACEL

Information

• Trademark
• 97613039

• Source

• Serial Number

  97613039

• Registration Number

  7297048

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 29, 2022
  2 years ago

• Registration Date

  February 06, 2024
  11 months ago

• Transaction Date

  February 06, 2024
  11 months ago

• Status Date

  February 06, 2024
  11 months ago

• Published for Opposition Date

  November 21, 2023
  a year ago

• Location Date

  February 06, 2024
  11 months ago

• First Use Anywhere Date

  August 31, 1997
  27 years ago

• First Use In Commerce Date

  September 30, 2003
  21 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CALLAGHAN, BRIAN P

• Attorney Docket Number

  DYOUNG-65-T

  Attorney Name

  Jeffrey A. Smith

  Law Office Assigned Location Code

  L80

• Owners

  • Cyclacel Limited

Case File Statements

• GS0051: Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; pharmaceutical preparations for human use for the treatment of cancer and hematological disorders
• TR0010: The wording "CYCLACEL" has no meaning in a foreign language.
• GS0421: Research services and laboratory research services in the nature of pharmaceutical development, pharmaceutical products development, development of pharmaceuticals for the treatment of cancer, development of products for the treatment of cancer, development of pharmaceuticals for the treatment of leukemia, development of pharmaceuticals for the treatment of hematological cancers, development of products for the treatment of leukemia, and development of products for the treatment of hematological cancers

Case File Event Statements

• 2/6/2024 - 11 months ago

  16 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 2/6/2024 - 11 months ago

  15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 11/21/2023 - a year ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/21/2023 - a year ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/1/2023 - a year ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/17/2023 - a year ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/17/2023 - a year ago

  10 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/17/2023 - a year ago

  9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/17/2023 - a year ago

  8 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/17/2023 - a year ago

  7 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 7/21/2023 - a year ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/21/2023 - a year ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/21/2023 - a year ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/13/2023 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/4/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/3/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP